FluLaval Quadrivalent Interactions
There are 296 drugs known to interact with FluLaval Quadrivalent (influenza virus vaccine, inactivated), along with 4 disease interactions. Of the total drug interactions, 1 is major, 290 are moderate, and5 are minor.
- View all 296 medications that may interact with FluLaval Quadrivalent
- View FluLaval Quadrivalent disease interactions (4)
Most frequently checked interactions
View interaction reports for FluLaval Quadrivalent (influenza virus vaccine, inactivated) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- aluminum hydroxide / magnesium carbonate
- Arexvy (rsv vaccine pref3, recombinant)
- Aspirin Low Strength (aspirin)
- atorvastatin
- baclofen
- boron
- calcium carbonate
- calcium citrate
- calcium / vitamin d
- carvedilol
- dicyclomine
- diphtheria toxoid / pertussis, acellular / tetanus toxoid
- Evamist (estradiol)
- Evening Primrose Oil (evening primrose)
- Excedrin (acetaminophen / aspirin / caffeine)
- fluoxetine
- Fosamax (alendronate)
- gabapentin
- Gaviscon Extra Strength (aluminum hydroxide / magnesium carbonate)
- hepatitis a adult vaccine
- hepatitis b adult vaccine
- hydrocodone
- hydroxyzine
- ibuprofen
- lamotrigine
- latanoprost ophthalmic
- leuprolide
- lidocaine ophthalmic
FluLaval Quadrivalent disease interactions
There are 4 disease interactions with FluLaval Quadrivalent (influenza virus vaccine, inactivated) which include:
More about FluLaval Quadrivalent (influenza virus vaccine, inactivated)
- FluLaval Quadrivalent consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.